Leading causes of death in patients surviving a first episode of iTTP and the general US population
| iTTP survivors (n = 29) . | General US population (2017, CDC) . |
|---|---|
| Relapsed iTTP (27.6%) | Cardiovascular disease (29.5%) |
| Cardiovascular disease (27.6%) | Cancer (21.3%) |
| Cancer (20.7%) | Accidents (6%) |
| Infectious causes (13.8%) | Chronic lung disease (5.7%) |
| Other/unknown (10.3%) | Alzheimer disease (4.3) |
| Infectious causes (3.5%) | |
| Diabetes (3%) | |
| Renal disease (1.8%) | |
| Intentional self-harm (1.8%) | |
| Cirrhosis (1.5%) | |
| Parkinson disease (1.1%) | |
| Pneumonitis (0.7%) | |
| All other causes (20%) |
| iTTP survivors (n = 29) . | General US population (2017, CDC) . |
|---|---|
| Relapsed iTTP (27.6%) | Cardiovascular disease (29.5%) |
| Cardiovascular disease (27.6%) | Cancer (21.3%) |
| Cancer (20.7%) | Accidents (6%) |
| Infectious causes (13.8%) | Chronic lung disease (5.7%) |
| Other/unknown (10.3%) | Alzheimer disease (4.3) |
| Infectious causes (3.5%) | |
| Diabetes (3%) | |
| Renal disease (1.8%) | |
| Intentional self-harm (1.8%) | |
| Cirrhosis (1.5%) | |
| Parkinson disease (1.1%) | |
| Pneumonitis (0.7%) | |
| All other causes (20%) |
CDC, Centers for Disease Control and Prevention.